NAGE Niagen Bioscience, Inc.

NASDAQ
$2.58

Niagen Bioscience, Inc. (NAGE) is confirmed to report earnings on November 4, 2026, after the market close. The consensus earnings estimate is $0.00 per share, and the stock has had a Post-Earnings Announcement Drift (PEAD) of -17.0% since its last earnings release on August 4, 2026.

Niagen Bioscience, Inc. Reported In-line with Estimates
Tuesday, August 4, 2026 · 4:02 PM ET
Earnings Date
3rd Quarter, Sep 2026
Nov 4
Wednesday · 4:00 PM ET
Earnings Whisper
-
vs $0.00
Rev est $30.15M
Volatility
Enter your expectations below to reveal the current volatility.
Trend Analysis
Expectation
Earnings
Price action
Signals
Score
Sentiment
Grade
Life Cycle
Call Analysis
Earnings-AVWAP $2.96

Sign in or subscribe to unlock sentiment, short interest, and technical indicators.

About Niagen Bioscience, Inc.

Niagen Bioscience, Inc. is the global leader in NAD+ (nicotinamide adenine dinucleotide) science and healthy-aging research.

Sector

Healthcare

Industry

Biotechnology

Held By 1 ETFs, by dollar flow

Charts powered in part by Lightweight Charts™ by TradingView.